Related Articles
Overexpression of miRNA-22-3p attenuates osteoporosis by targeting MAPK14
P2X7 receptor knockdown suppresses osteoclast differentiation by inhibiting autophagy and Ca<sup>2+</sup>/calcineurin signaling
Zoledronic acid inhibits osteoclastogenesis and bone resorptive function by suppressing RANKL‑mediated NF‑κB and JNK and their downstream signalling pathways
Advanced glycation end products promote osteoporosis by inducing ferroptosis in osteoblasts
Casticin suppresses RANKL‑induced osteoclastogenesis and prevents ovariectomy‑induced bone loss by regulating the AKT/ERK and NF‑κB signaling pathways